EVALUATION OF NO EVIDENCE OF PROGRESSION OR ACTIVE DISEASE (NEPAD) IN PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS IN THE ORATORIO TRIAL

被引：0
|
作者：
Wolinsky, Jerry [1 ]
Montalban, Xavier [2 ]
Kappos, Ludwig [3 ]
Hauser, Stephen [4 ]
Giovannoni, Gavin [5 ]
de Seze, Jerome [6 ]
Bar-Or, Amit [7 ]
Masterman, Donna [8 ]
Bernasconi, Corrado [9 ]
Wei, Wei [9 ]
Garren, Hideki [9 ]
Chin, Peter [8 ]
Belachew, Shibeshih [9 ]
Arnold, Doug L. [10 ,11 ]
机构：
[1] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA
[2] Vall dHebron Univ Hosp, Barcelona, Spain
[3] Univ Hosp, Basel, Switzerland
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Queen Mary Univ London, London, England
[6] Univ Hosp Strasbourg, Strasbourg, France
[7] Univ Penn, Philadelphia, PA 19104 USA
[8] Genentech Inc, San Francisco, CA 94080 USA
[9] F Hoffmann La Roche Ltd, Basel, Switzerland
[10] McGill Univ, Montreal, PQ, Canada
[11] NeuroRx Res, Montreal, PQ, Canada
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2017年 / 88卷 / 05期
关键词：
D O I：
10.1136/jnnp-2017-316074.83
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
83
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Evaluation of No Evidence of Progression or Active Disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Montalban, X.
    Wolinsky, J.
    Kappos, L.
    Hauser, S. L.
    Giovannoni, G.
    de Seze, J.
    Bar-or, A.
    Masterman, D.
    Bernasconi, C.
    Wei, W.
    Garren, H.
    Chin, P.
    Belachew, S.
    Arnold, D. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 576 - 576
  • [2] Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Montalban, Xavier
    Wolinsky, Jerry
    Kappos, Ludwig
    Hauser, Stephen L.
    Giovannoni, Gavin
    de Seze, Jerome
    Bar-Or, Amit
    Masterman, Donna
    Bernasconi, Corrado
    Wei, Wei
    Garren, Hideki
    Chin, P.
    Belachew, S.
    Arnold, D. L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP10 - NP10
  • [3] Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Wolinsky, Jerry S.
    Montalban, Xavier
    Hauser, Stephen L.
    Giovannoni, Gavin
    Vermersch, Patrick
    Bernasconi, Corrado
    Deol-Bhullar, Gurpreet
    Garren, Hideki
    Chin, Peter
    Belachew, Shibeshih
    Kappos, Ludwig
    ANNALS OF NEUROLOGY, 2018, 84 (04) : 527 - 536
  • [4] Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients with Primary Progressive Multiple Sclerosis in the ORATORIO Trial
    Wolinsky, Jerry
    Montalban, Xavier
    Kappos, Ludwig
    Hauser, Stephen
    Giovannoni, Gavin
    de Seze, Jerome
    Bar-Or, Amit
    Masterman, Donna
    Bemasconi, Corrado
    Wei, Wei
    Garren, Hideki
    Chin, Peter
    Belachew, Shibeshih
    Arnold, Douglas
    NEUROLOGY, 2017, 88
  • [5] Evaluation of no evidence of progression (NEP) in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Wolinsky, Jerry
    Montalban, Xavier
    Arnold, Douglas L.
    Bar-Or, Amit
    de Seze, Jerome
    Giovannoni, Gavin
    Hemmer, Bernhard
    Rammohan, Kottil W.
    Deol-Bhullar, Gurpreet
    Masterman, Donna
    Wei, Wei
    Chin, Peter
    Bernasconi, Corrado
    Belachew, Shibeshih
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 17 - 17
  • [6] Evaluation of no evidence of progression using composite disability outcome measures, in patients with primary progressive multiple sclerosis in the ORATORIO trial.
    Montalban, X.
    Arnold, D. L.
    Bar-Or, A.
    De Seze, J.
    Giovannoni, G.
    Hemmer, B.
    Rammohan, K.
    Masterman, D.
    Bernasconi, C.
    Wei, W.
    Belachew, S.
    Chin, P.
    Wolinsky, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 50 - 51
  • [7] Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients with Relapsing Multiple Sclerosis in the OPERA I and OPERA II Trials
    Traboulsee, Anthony
    Arnold, Douglas L.
    Bar-Or, Amit
    Comi, Giancarlo
    Giovannoni, Gavin
    Hartung, Hans-Peter
    Hauser, Stephen L.
    Kappos, Ludwig
    Lublin, Fred
    Selmaj, Krzysztof W.
    Belachew, Shibeshih
    Bernasconi, Corrado
    Buffels, Regine
    Wei, Wei
    Julian, Laura
    Havrdova, Eva
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 17 - 17
  • [8] Evaluation of No Evidence of Progression or Active Disease (NEPAD) in patients with relapsing multiple sclerosis in the OPERA I and OPERA II trials
    Havrdova, E.
    Arnold, D. L.
    Bar-or, A.
    Comi, G.
    Giovannoni, G.
    Hartung, H-P.
    Hauser, S. L.
    Kappos, L.
    Lublin, F.
    Selmaj, K.
    Belachew, S.
    Bernasconi, C.
    Buffels, R.
    Wei, W.
    Traboulsee, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 497 - 497
  • [9] Effect of Ocrelizumab on Severe Progression of Upper Extremity Impairment in Patients with Primary Progressive Multiple Sclerosis in ORATORIO
    Fox, Edward J.
    Markowitz, Clyde
    Applebee, Angela
    Montalban, Xavier
    Wolinsky, Jerry S.
    Belachew, Shibeshih
    Fiore, Damian
    Pei, Jinglan
    Musch, Bruno
    Giovannoni, Gavin
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 33 - 34
  • [10] An exploratory analysis of the risk of being restricted to wheelchair in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Giovannoni, G.
    de Seze, J.
    Kappos, L.
    Montalban, X.
    Hauser, S. L.
    Belachew, S.
    Bernasconi, C.
    Buffels, R.
    Chin, P.
    Deol-Bhullar, G.
    Wolinsky, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 494 - 494
12345